Jeffrey H. Chen
- Oncology top 5%
- Molecular Biology top 10%
- PI3K/AKT/mTOR signaling in cancer 4
- Angiogenesis and VEGF in Cancer 2
- Glycosylation and Glycoproteins Research 1
- Protein Kinase Regulation and GTPase Signaling 1
- Toxicology top 5%
- Cancer Research top 10%
- Organic Chemistry top 5%
- Quinazolinone synthesis and applications 2
- Synthesis and biological activity 1
-
- Renal cell carcinoma treatment 2
-
- Cancer Mechanisms and Therapy 1
- Co-authors
- Brion W. MurrayRobert S. KaniaMichele McTigueJames SolowiejYali DengAnjali BabbarPingda RenTess Ely
- Cited by
- OncologyMolecular BiologyToxicology
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Cancer Research (1 paper)Clinical Cancer Research (1 paper)
- Partner nations
- United StatesChina
In The Last Decade
Jeffrey H. Chen
7 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 91
- Oncology 520
- Molecular Biology 1.0k
- Toxicology 49
- Cancer Research 207
- Organic Chemistry 361
Countries citing papers authored by Jeffrey H. Chen
This map shows the geographic impact of Jeffrey H. Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey H. Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey H. Chen more than expected).
Fields of papers citing papers by Jeffrey H. Chen
This network shows the impact of papers produced by Jeffrey H. Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey H. Chen. The network helps show where Jeffrey H. Chen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jeffrey H. Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Selective Inhibition of Oncogenic KRAS Output with Small Molecules Targeting the Inactive Statebreakdown → | 2016 | 530 |
| 2 | 2013 | 4 | |
| 3 | Molecular conformations, interactions, and properties associated with drug efficiency and clinical performance among VEGFR TK inhibitorsbreakdown → | 2012 | 451 |
| 4 | 2011 | 23 | |
| 5 | 2010 | 20 | |
| 6 | 2010 | 26 | |
| 7 | Nonclinical Antiangiogenesis and Antitumor Activities of Axitinib (AG-013736), an Oral, Potent, and Selective Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases 1, 2, 3breakdown → | 2008 | 515 |
About Jeffrey H. Chen
Jeffrey H. Chen is a scholar working on Immunology and Allergy, Molecular Biology and Organic Chemistry, having authored 7 papers that have together received 1.6k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (4 papers), Renal cell carcinoma treatment (2 papers), Angiogenesis and VEGF in Cancer (2 papers), Quinazolinone synthesis and applications (2 papers), Glycosylation and Glycoproteins Research (1 paper), Protein Kinase Regulation and GTPase Signaling (1 paper), Synthesis and biological activity (1 paper) and Cancer Mechanisms and Therapy (1 paper). The work is most often cited by research in Oncology (520 citations), Molecular Biology (1.0k citations) and Toxicology (49 citations). Jeffrey H. Chen has collaborated with scholars based in United States and China. Frequent co-authors include Brion W. Murray, Robert S. Kania, Michele McTigue, James Solowiej, Yali Deng, Anjali Babbar, Pingda Ren, Tess Ely, Matthew R. Janes and Lian‐Sheng Li. Their work appears in journals such as Proceedings of the National Academy of Sciences, Cancer Research and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.